Heung-Moon Chang

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Se Hoon Park, Heung-Moon Chang, Jun Suk Kim et al. · The Lancet Oncology · 2011 · 483 citations

Medicine, Oncology, Pharmacology +9

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Yoon‐Koo Kang, Sung Sook Lee, Dok Hyun Yoon et al. · Journal of Clinical Oncology · 2010 · 129 citations · Full text

Medicine, Oncology, Pharmacology +16

Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?

Young Soo Park, Hee Sang Hwang, Hye Jin Park et al. · Human Pathology · 2011 · 68 citations

Medicine, Molecular Biology, Oncology +17

TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

Tatsuya Ioka, Makoto Ueno, Hideki Ueno et al. · European Journal of Cancer · 2018 · 33 citations · Full text

Medicine, Oncology, Pharmacology +15

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)

Yoon‐Koo Kang, Jeong Hwan Yook, Heung-Moon Chang et al. · Cancer Chemotherapy and Pharmacology · 2013 · 29 citations

Medicine, Oncology, Surgery +11